MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement

New Cannabis Ventures
By NCV NewswireOct 10, 2018, 10:16 am128 ptsTrending
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (“MediPharm”) (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the “Agreement”) with Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH – OTCQX:EMHTF). Pursuant to the Agreement, signed on…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

The Cannabis Seed Economy: How Genetics Became the Industry’s Most Valuable Asset 76

Rubicon Organics secures $4 million in financing from Community Savings 75

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 71

Missouri Officials Propose Tightening Cannabis Licensing Rules 50

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.